Background There are substantial advances in diagnosis and treatment for idiopathic
pulmonary fibrosis (IPF), but without much evidence available on recent mortality and …

In addition to facilitating healthcare delivery planning, reliable information about prognosis is
essential for treatment decisions in patients with idiopathic pulmonary fibrosis (IPF). This …

Rationale: The association between idiopathic pulmonary fibrosis (IPF) and lung cancer has
been previously reported. However, there is the potential for significant confounding by age …

Background Several registries of idiopathic pulmonary fibrosis (IPF) have been established
to better understand its natural history, though their size and duration of follow-up are …

Background Interstitial lung disease (ILD) is an important cause of morbidity and mortality in
patients with scleroderma (Scl). Risk prediction and prognostication in patients with Scl-ILD …

Background There are many epidemiological pieces of evidence that show IPF patients
have the highest risk of lung cancer. We conducted a systematic review of all published data …

Background Cigarette smoking has been associated with the risk of idiopathic pulmonary
fibrosis (IPF). Certain comorbidities have been associated with reduced survival although …

Background Total lung capacity (TLC) has been estimated with use of chest radiographs
based on time-consuming methods, such as planimetric techniques and manual …

The recommendation for pulmonary rehabilitation (PR) in idiopathic pulmonary fibrosis (IPF)
is weak with low-quality evidence. Therefore, the aim of this study is to investigate short-term …

Background Mortality is an impractical primary endpoint for clinical trials in patients with
idiopathic pulmonary fibrosis who have mild-to-moderate physiological impairment because …